Drugmaker Teva hires new CEO to restore its health

ReutersNewsPublished: September 11, 2017
Published: September 11, 2017

Teva Pharmaceutical Industries Ltd names H Lundbeck A/S Chief Executive Kare Schultz as its new CEO and president, as it struggles with heavy debts and fierce competition for its generic drugs in the United States. Amy Pollock reports

Be the first to suggest a tag

    Comments

    0 comments